Browse category
General
Everyday acronyms and abbreviations from a wide range of subjects.
PROGRESS
The Enemy of the Good: Towards a Theory of Moral Progress
EU Funded (H2020) Research Project
PROGRESS
TIPS or Anticoagulation in Portal Vein Thrombosis
clinical trial
PROGRESS
Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)
clinical trial
PROMINENT
Personalised Medicine in Diabetic Chronic Disease Management
EU Funded (H2020) Research Project
PROMINENT
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
clinical trial
PROMISS
PRevention Of Malnutrition In Senior Subjects in the EU
EU Funded (H2020) Research Project
PROMISS
Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
clinical trial
PROMISS
PROphylactic Mesh to Prevent Incisional Hernias at the Former Stoma Site: the PROMISS-trial
clinical trial
PRONECMO
PRONing to Facilitate Weaning From ECMO in Patients With Refractory Acute Respiratory Distress Syndrome
clinical trial
PRONKJEWAIL
Protecting patients with enhanced susceptibility to infections
EU Funded (H2020) Research Project
PROPEL
Prophylactic Negative Wound Therapy in Laparotomy Wounds.
clinical trial
PROPEL
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
clinical trial
PROPEL
Propranolol Rescue of Prolonged Labor
clinical trial
PROPEL
Protecting From Pneumococcus in Early Life (The PROPEL Trial)
clinical trial
PROPEL
Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease
clinical trial
PROPEL
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
clinical trial
PROPEL
Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)
clinical trial
PROPEL
BAX 855 PK-guided Dosing
clinical trial
PROPEL
A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 (Pembrolizumab) and of NKTR-214 in Combination With Anti-PD-L1 (Atezolizumab) in Patients With Select Advanced or Metastatic Solid Tumors
clinical trial
PROPEL
Intravenous Zotatifin in Adults With Mild or Moderate COVID-19
clinical trial
PROPEL
Pelvic Floor Repair Systems for Prolapse Repair
clinical trial
PROPEL
Promoting Successful Weight Loss in Primary Care in Louisiana
clinical trial
PROPEL
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
clinical trial
PROPEL
Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients.
clinical trial
PROPHETIC
Identification of Biomarkers of Tofacitinib Therapy in Patients With Ulcerative Colitis
clinical trial
PROPHETIC
CTTI Risk Factors for HABP/VABP Study
clinical trial
PROPHETIC
Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
clinical trial
PROPHETIC
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
clinical trial
PROPTER
Support to aerodynamic analysis and design of propellers of a compound helicopter
EU Funded (H2020) Research Project
PROSOCIAL
The neural basis of prosocial development in adolescence
EU Funded (H2020) Research Project
PROSPER
Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
clinical trial
PROSPER
Preventing Relapse to Smoking Among Prisoners After Release
clinical trial
PROSPER
Prevention & Promotion in the Treatment of Obesity
clinical trial
PROSPER
PROductivity Study of Presbyopia Elimination in Rural-dwellers (PROSPER)
clinical trial
PROSPER
Profiling of Oncology Patients as Part of Clinical Care and Research
clinical trial
PROSPER
PROSpective Assessment of Post EmR Recurrence
clinical trial
PROSPER
Endophthalmitis Cultures
clinical trial
PROSPER
Psychological and Enterostomal Therapy Care
clinical trial
PROSPER
Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)
clinical trial
PROSPER
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
clinical trial